GSE178521 PD-L1 inhibition lung 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE178521_PD-L1 inhibition_lung_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE178521_PD-L1 inhibition_lung_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE178521_PD-L1 inhibition_lung_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE178521_PD-L1 inhibition_lung_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

JPX transcript, XIST activator

Gene

MIRLET7I host gene

Gene

uncharacterized LOC124904294

Gene

lncRNA EGFL7 opposite strand

Gene

BCL2 interacting protein 3 pseudogene 28

Gene

uncharacterized LOC101928093

Gene

long intergenic non-protein coding RNA 3135

Gene

ribosomal protein L7 pseudogene 11

Gene

CNTFR antisense RNA 1

Gene

REL divergent transcript

  • Gene

    JPX transcript, XIST activator



  • Gene

    uncharacterized LOC124904294


  • Gene

    lncRNA EGFL7 opposite strand


  • Gene

    BCL2 interacting protein 3 pseudogene 28


  • Gene

    uncharacterized LOC101928093


  • Gene

    long intergenic non-protein coding RNA 3135


  • Gene

    ribosomal protein L7 pseudogene 11


  • Gene

    CNTFR antisense RNA 1


  • Gene

    REL divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.